Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 9/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | HTR7 | P34969 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL28529671 | 0.88 | TAAR1 (0.47) | TAAR1HTR1ADRD2HTR7 | |
| Trifluoromethanesulfonic Acid SCHEMBL29140410 | 0.78 | TAAR1 (0.44) | TAAR1HTR1ADRD2HTR7 | |
| SCHEMBL28517977 | 0.78 | TAAR1 (0.51) | TAAR1HTR1ADRD2HTR7 | |
| Ulotaront SCHEMBL21273317 | 0.76 | TAAR1 (0.74) | TAAR1HTR1ADRD2HTR7 | |
| SCHEMBL30733601 | 0.73 | TAAR1 (0.60) | TAAR1HTR1ADRD2HTR7 | |
| SCHEMBL28511085 | 0.73 | TAAR1 (0.60) | TAAR1HTR1ADRD2HTR7 | |
| SCHEMBL28511084 | 0.73 | TAAR1 (0.60) | TAAR1HTR1ADRD2HTR7 | |
| Hydrochloric Acid SCHEMBL29140413 | 0.72 | TAAR1 (0.59) | TAAR1HTR1ADRD2HTR7 | |
| Hydrochloric Acid SCHEMBL28522435 | 0.72 | TAAR1 (0.59) | TAAR1HTR1ADRD2HTR7 | |
| Hydrochloric Acid SCHEMBL30733605 | 0.72 | TAAR1 (0.59) | TAAR1HTR1ADRD2HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115734785-A | (S) - (4, 5-dihydro-7H-thieno [2,3-c ] pyran-7-yl) -N-methylmethanamine for the treatment of neurological and psychiatric disorders | 桑诺维恩药品公司 | 2023-03-03 | — | — | CN | disclosed |
| CN-113271936-A | Method for treating neurological and psychiatric disorders | 赛诺维信制药公司 | 2021-08-17 | — | — | CN | disclosed |
| CN-112135827-A | Salts, crystalline forms and methods for preparing the same | 赛诺维信制药公司 | 2020-12-25 | — | — | CN | disclosed |